<p>Praxis Investment Management Inc. 在最近向证券交易委员会提交的 13F 表格中表示，在第二季度将其在坎贝尔公司（NASDAQ:CPB - 免费报告）的股份增加了 123.2%。该基金在此期间购买了额外的 8,280 股后，持有该公司 15,000 股股票。根据其最近的 SEC 文件，Praxis Investment Management Inc. 在坎贝尔的持股价值为 460,000 美元。</p>
<ul>
<li>接近 52 周低点，这 3 只中型股值得关注</li>
</ul>
<p>其他对冲基金也调整了对该公司的持股。Ameritas Advisory Services LLC 在第二季度购买了价值 25,000 美元的坎贝尔新股份。Manchester Capital Management LLC 在第一季度将其在坎贝尔的持股增加了 923.2%。Manchester Capital Management LLC 现在拥有 706 股该公司的股票，价值 28,000 美元，此前在上个季度购买了额外的 637 股。ORG Partners LLC 在第二季度将其在坎贝尔的持股增加了 77.3%。ORG Partners LLC 现在拥有 906 股该公司的股票，价值 29,000 美元，此前在上个季度购买了额外的 395 股。Geneos Wealth Management Inc. 在第一季度将其在坎贝尔的持股增加了 333.3%。Geneos Wealth Management Inc. 现在拥有 975 股该公司的股票，价值 39,000 美元，此前在上个季度购买了额外的 750 股。最后，Banque Cantonale Vaudoise 在第一季度购买了价值约 47,000 美元的坎贝尔新股份。52.35% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>坎贝尔的价格表现</h2>
<p>CPB 的股票在周五开盘价为 30.86 美元。该公司的市值为 91.9 亿美元，市盈率为 15.43，市盈增长比率为 10.72，贝塔系数为 0.02。该公司的 50 日移动平均价格为 32.23 美元，200 日移动平均价格为 33.42 美元。该公司的债务与股本比率为 1.56，速动比率为 0.28，流动比率为 0.77。坎贝尔公司的 12 个月低点为 29.39 美元，12 个月高点为 48.68 美元。</p>
<ul>
<li>3 只股票呈现出世代购买机会</li>
</ul>
<p>坎贝尔（NASDAQ:CPB - 获取免费报告）最近在 9 月 3 日星期三发布了季度财报。该公司报告本季度每股收益为 0.62 美元，超出市场共识预期的 0.57 美元，超出 0.05 美元。该公司本季度的收入为 23.2 亿美元，而分析师预期为 23.3 亿美元。坎贝尔的净利润率为 5.87%，股本回报率为 22.95%。该公司的季度收入同比增长 1.2%。去年同期，该公司每股收益为 3.08 美元。坎贝尔已将其 2026 财年的指引设定为每股收益 2.400-2.550。整体而言，研究分析师预计坎贝尔公司本财年将发布 3.15 的每股收益。</p>
<h2>坎贝尔的股息公告</h2>
<p>该公司最近还披露了季度股息，将于 11 月 3 日星期一支付。10 月 2 日星期四的登记股东将获得每股 0.39 美元的股息。该股息的除息日为 10 月 2 日星期四。这相当于每年 1.56 美元的股息，股息收益率为 5.1%。坎贝尔的股息支付比率目前为 78.00%。</p>
<h2>华尔街分析师的看法</h2>
<ul>
<li>坎贝尔的股票在 2025 年可能带来丰厚回报的 4 个理由</li>
</ul>
<p>几位股票研究分析师最近对该公司发布了报告。富国银行将坎贝尔的目标价从 32.00 美元上调至 34.00 美元，并在 9 月 25 日星期四的研究报告中给予该股 “持平” 评级。Stifel Nicolaus 将坎贝尔的目标价从 38.00 美元下调至 34.00 美元，并在 7 月 29 日星期二的研究报告中对该公司给予 “持有” 评级。TD Cowen 将坎贝尔的目标价从 29.00 美元上调至 31.00 美元，并在 9 月 4 日星期四的研究报告中给予该股 “持有” 评级。摩根大通在 8 月 20 日星期三的研究报告中开始覆盖坎贝尔。他们给予该公司 “中性” 评级，目标价为 33.00 美元。最后，摩根士丹利将坎贝尔的目标价从 32.00 美元上调至 33.00 美元，并在 9 月 5 日星期五的研究报告中给予该股 “持平” 评级。三位股票研究分析师对该股给予买入评级，十五位给予持有评级，五位给予卖出评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “减持”，共识目标价为 34.82 美元。</p>
<p><strong>查看我们关于坎贝尔的最新研究报告</strong></p>
<h2>坎贝尔的公司简介</h2>
<p>（免费报告）</p>
<p>坎贝尔公司，前身为坎贝尔汤公司，及其子公司在美国和国际上制造和销售食品和饮料产品。该公司通过餐饮和饮料以及零食两个部门运营。餐饮和饮料部门从事美国和加拿大的零售和餐饮服务业务。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票超过坎贝尔</li>
<li>股票回购是什么？投资者的全面指南</li>
<li>强生的并购战略才是投资者真正关注的故事</li>
<li>什么是稀释每股收益（Diluted EPS）？</li>
<li>特斯拉：一些分析师预测将下跌 30%——是时候恐慌了吗？</li>
<li>零售股票投资，解释</li>
<li>对冲基金对美元的态度转变——这 3 只股票的买入信号？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1BC?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1BC"/></p>
<p><em>此即时新闻提醒是由叙事科学技术和 MarketBeat 的金融数据生成的，旨在为读者提供最快和最准确的报道。此故事在发布前经过了 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在康宝浓汤吗？</h2>
<p>在考虑康宝浓汤之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而康宝浓汤并不在名单上。</p>
<p>虽然康宝浓汤目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

康宝浓汤

<p>Praxis Investment Management Inc. 在第二季度将其在康宝浓汤公司（NASDAQ:CPB）的持股增加了 123.2%，目前拥有 15,000 股，价值 46 万美元。其他对冲基金也调整了他们的持股。康宝浓汤报告了第三季度每股收益为 0.62 美元，超出预期，收入为 23.2 亿美元。该公司宣布季度股息为每股 0.39 美元，收益率为 5.1%。分析师对该股票的评级不一，目标价格范围在 29 美元到 38 美元之间</p>

<p>Praxis Investment Management Inc. grew its stake in shares of The Campbell's Company (NASDAQ:CPB - Free Report) by 123.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The fund owned 15,000 shares of the company's stock after purchasing an additional 8,280 shares during the period. Praxis Investment Management Inc.'s holdings in Campbell's were worth $460,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Praxis Investment Management Inc. 在最近向证券交易委员会提交的 13F 表格中表示，在第二季度将其在坎贝尔公司（NASDAQ:CPB - 免费报告）的股份增加了 123.2%。该基金在此期间购买了额外的 8,280 股后，持有该公司 15,000 股股票。根据其最近的 SEC 文件，Praxis Investment Management Inc. 在坎贝尔的持股价值为 460,000 美元。</p>
</div><ul>
<li>Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look</li>
</ul>
<div class="lb-trans"><ul>
<li>接近 52 周低点，这 3 只中型股值得关注</li>
</ul>
</div><p>Other hedge funds have also modified their holdings of the company. Ameritas Advisory Services LLC purchased a new stake in shares of Campbell's during the second quarter valued at $25,000. Manchester Capital Management LLC lifted its holdings in shares of Campbell's by 923.2% during the first quarter. Manchester Capital Management LLC now owns 706 shares of the company's stock valued at $28,000 after purchasing an additional 637 shares during the last quarter. ORG Partners LLC lifted its holdings in shares of Campbell's by 77.3% during the second quarter. ORG Partners LLC now owns 906 shares of the company's stock valued at $29,000 after purchasing an additional 395 shares during the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of Campbell's by 333.3% during the first quarter. Geneos Wealth Management Inc. now owns 975 shares of the company's stock valued at $39,000 after purchasing an additional 750 shares during the last quarter. Finally, Banque Cantonale Vaudoise purchased a new stake in Campbell's in the 1st quarter worth about $47,000. 52.35% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他对冲基金也调整了对该公司的持股。Ameritas Advisory Services LLC 在第二季度购买了价值 25,000 美元的坎贝尔新股份。Manchester Capital Management LLC 在第一季度将其在坎贝尔的持股增加了 923.2%。Manchester Capital Management LLC 现在拥有 706 股该公司的股票，价值 28,000 美元，此前在上个季度购买了额外的 637 股。ORG Partners LLC 在第二季度将其在坎贝尔的持股增加了 77.3%。ORG Partners LLC 现在拥有 906 股该公司的股票，价值 29,000 美元，此前在上个季度购买了额外的 395 股。Geneos Wealth Management Inc. 在第一季度将其在坎贝尔的持股增加了 333.3%。Geneos Wealth Management Inc. 现在拥有 975 股该公司的股票，价值 39,000 美元，此前在上个季度购买了额外的 750 股。最后，Banque Cantonale Vaudoise 在第一季度购买了价值约 47,000 美元的坎贝尔新股份。52.35% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Campbell's Price Performance</h2>
<div class="lb-trans"><h2>坎贝尔的价格表现</h2>
</div><p>Shares of CPB opened at $30.86 on Friday. The firm has a market cap of $9.19 billion, a PE ratio of 15.43, a PEG ratio of 10.72 and a beta of 0.02. The firm's 50 day moving average price is $32.23 and its 200 day moving average price is $33.42. The company has a debt-to-equity ratio of 1.56, a quick ratio of 0.28 and a current ratio of 0.77. The Campbell's Company has a twelve month low of $29.39 and a twelve month high of $48.68.</p>
<div class="lb-trans"><p>CPB 的股票在周五开盘价为 30.86 美元。该公司的市值为 91.9 亿美元，市盈率为 15.43，市盈增长比率为 10.72，贝塔系数为 0.02。该公司的 50 日移动平均价格为 32.23 美元，200 日移动平均价格为 33.42 美元。该公司的债务与股本比率为 1.56，速动比率为 0.28，流动比率为 0.77。坎贝尔公司的 12 个月低点为 29.39 美元，12 个月高点为 48.68 美元。</p>
</div><ul>
<li>3 Stocks Presenting Generational Buying Opportunities</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只股票呈现出世代购买机会</li>
</ul>
</div><p>Campbell's (NASDAQ:CPB - Get Free Report) last issued its quarterly earnings data on Wednesday, September 3rd. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.05. The firm had revenue of $2.32 billion for the quarter, compared to analyst estimates of $2.33 billion. Campbell's had a net margin of 5.87% and a return on equity of 22.95%. The company's revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter last year, the firm earned $3.08 earnings per share. Campbell's has set its FY 2026 guidance at 2.400-2.550 EPS. As a group, research analysts expect that The Campbell's Company will post 3.15 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>坎贝尔（NASDAQ:CPB - 获取免费报告）最近在 9 月 3 日星期三发布了季度财报。该公司报告本季度每股收益为 0.62 美元，超出市场共识预期的 0.57 美元，超出 0.05 美元。该公司本季度的收入为 23.2 亿美元，而分析师预期为 23.3 亿美元。坎贝尔的净利润率为 5.87%，股本回报率为 22.95%。该公司的季度收入同比增长 1.2%。去年同期，该公司每股收益为 3.08 美元。坎贝尔已将其 2026 财年的指引设定为每股收益 2.400-2.550。整体而言，研究分析师预计坎贝尔公司本财年将发布 3.15 的每股收益。</p>
</div><h2>Campbell's Dividend Announcement</h2>
<div class="lb-trans"><h2>坎贝尔的股息公告</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 2nd will be issued a dividend of $0.39 per share. The ex-dividend date of this dividend is Thursday, October 2nd. This represents a $1.56 dividend on an annualized basis and a dividend yield of 5.1%. Campbell's's dividend payout ratio is currently 78.00%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，将于 11 月 3 日星期一支付。10 月 2 日星期四的登记股东将获得每股 0.39 美元的股息。该股息的除息日为 10 月 2 日星期四。这相当于每年 1.56 美元的股息，股息收益率为 5.1%。坎贝尔的股息支付比率目前为 78.00%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师的看法</h2>
</div><ul>
<li>4 Reasons Campbell’s Stock Could Serve Up Big Returns in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>坎贝尔的股票在 2025 年可能带来丰厚回报的 4 个理由</li>
</ul>
</div><p>Several equities research analysts recently issued reports on the company. Wells Fargo &amp; Company increased their price objective on Campbell's from $32.00 to $34.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Thursday, September 25th. Stifel Nicolaus reduced their price objective on Campbell's from $38.00 to $34.00 and set a &#34;hold&#34; rating for the company in a research note on Tuesday, July 29th. TD Cowen increased their price objective on Campbell's from $29.00 to $31.00 and gave the stock a &#34;hold&#34; rating in a research note on Thursday, September 4th. JPMorgan Chase &amp; Co. assumed coverage on Campbell's in a research note on Wednesday, August 20th. They issued a &#34;neutral&#34; rating and a $33.00 price objective for the company. Finally, Morgan Stanley increased their price objective on Campbell's from $32.00 to $33.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Friday, September 5th. Three equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of &#34;Reduce&#34; and a consensus target price of $34.82.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对该公司发布了报告。富国银行将坎贝尔的目标价从 32.00 美元上调至 34.00 美元，并在 9 月 25 日星期四的研究报告中给予该股 “持平” 评级。Stifel Nicolaus 将坎贝尔的目标价从 38.00 美元下调至 34.00 美元，并在 7 月 29 日星期二的研究报告中对该公司给予 “持有” 评级。TD Cowen 将坎贝尔的目标价从 29.00 美元上调至 31.00 美元，并在 9 月 4 日星期四的研究报告中给予该股 “持有” 评级。摩根大通在 8 月 20 日星期三的研究报告中开始覆盖坎贝尔。他们给予该公司 “中性” 评级，目标价为 33.00 美元。最后，摩根士丹利将坎贝尔的目标价从 32.00 美元上调至 33.00 美元，并在 9 月 5 日星期五的研究报告中给予该股 “持平” 评级。三位股票研究分析师对该股给予买入评级，十五位给予持有评级，五位给予卖出评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “减持”，共识目标价为 34.82 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on Campbell's</strong></p>
<div class="lb-trans"><p><strong>查看我们关于坎贝尔的最新研究报告</strong></p>
</div><h2>Campbell's Profile</h2>
<div class="lb-trans"><h2>坎贝尔的公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>The Campbell's Company, formerly known as Campbell Soup Company, together with its subsidiaries, manufactures and markets food and beverage products in the United States and internationally. The company operates through Meals &amp; Beverages and Snacks segments. The Meals &amp; Beverages segment engages in the retail and foodservice businesses in the United States and Canada.</p>
<div class="lb-trans"><p>坎贝尔公司，前身为坎贝尔汤公司，及其子公司在美国和国际上制造和销售食品和饮料产品。该公司通过餐饮和饮料以及零食两个部门运营。餐饮和饮料部门从事美国和加拿大的零售和餐饮服务业务。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Campbell's</li>
<li>What is a buyback in stocks? A comprehensive guide for investors</li>
<li>Johnson &amp; Johnson's M&amp;A Strategy Is the Real Story for Investors</li>
<li>What is diluted earnings per share (Diluted EPS)?</li>
<li>Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?</li>
<li>Retail Stocks Investing, Explained</li>
<li>Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过坎贝尔</li>
<li>股票回购是什么？投资者的全面指南</li>
<li>强生的并购战略才是投资者真正关注的故事</li>
<li>什么是稀释每股收益（Diluted EPS）？</li>
<li>特斯拉：一些分析师预测将下跌 30%——是时候恐慌了吗？</li>
<li>零售股票投资，解释</li>
<li>对冲基金对美元的态度转变——这 3 只股票的买入信号？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1BC" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=CPB"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒是由叙事科学技术和 MarketBeat 的金融数据生成的，旨在为读者提供最快和最准确的报道。此故事在发布前经过了 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Campbell's Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在康宝浓汤吗？</h2>
</div><p>Before you consider Campbell's, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑康宝浓汤之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Campbell's wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而康宝浓汤并不在名单上。</p>
</div><p>While Campbell's currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然康宝浓汤目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Praxis 投资管理公司增持了康宝浓汤公司 $CPB 的持股